DeutschNewstral
Article
jdsupra.com on 2024-05-04 01:50
Genentech, Inc. v. Sandoz, Inc. - Esbriet® (Pirfenidone)
Related news
- Genentech, Inc. v. Sandoz Inc.jdsupra.com
- Genentech, Inc. v. Sandoz, Inc.jdsupra.com
- Sandoz Inc. v. Amgen Inc.,jdsupra.com
- Amgen Inc. v. Sandoz Inc.jdsupra.com
- Sandoz Inc. v Amgen Inc.jdsupra.com
- Allergan, Inc., v. Sandoz Inc.jdsupra.com
- Teva Pharms USA, Inc. v. Sandoz, Inc.jdsupra.com
- Amgen Inc. v. Sandoz Inc, No. 2022-1147 (Fed. Cir. Apr. 19, 2023)jdsupra.com
- Sandoz Inc. v. Amgen Inc. (2017)jdsupra.com
- Teva Pharms. USA, Inc., v. Sandoz, Inc.jdsupra.com
- Insite Vision Inc. v. Sandoz, Inc.jdsupra.com
- Amgen Inc. v. Sandoz Inc. Otezla® (Apremilast)jdsupra.com
- Spectrum Pharms., Inc. v. Sandoz Inc.,jdsupra.com
- Mitsubishi Tanabe Pharma Co. v. Sandoz, Inc.jdsupra.com
- Celltrion, Inc. v. Genentech, Inc. (N.D. Cal. 2018)jdsupra.com
- Baxalta Inc. v. Genentech, Inc. (Fed. Cir. 2023)jdsupra.com
- Merck Sharp & Dohme Corp. v. Sandoz Inc.jdsupra.com
- Allergan Sales, LLC v. Sandoz, Inc.jdsupra.com
- Genentech, Inc. v. Sandoz Inc. (Fed. Cir. 2022)jdsupra.com
- Spectrum Pharmaceuticals Inc. v. Sandoz Inc. (Fed. Cir. 2015)jdsupra.com